| Name | Title | Contact Details |
|---|---|---|
Lauren Brown |
Associate General Counsel | Profile |
Peggy Bui |
Associate General Counsel | Profile |
Stephen MacGuidwin |
Global Compliance Officer and Associate General Counsel | Profile |
Brian Inacay |
Associate General Counsel | Profile |
Increase enrollment, retention, & student success with Ocelot student engagement software. AI-powered text campaigns, Chatbot, Live Chat & an unrivaled knowledge base.
High-Impact Digital Advertising
Proficient Computing Solutions Corp. is a Columbus, OH-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.